Abstract |
A large multi-center, double-blind, parallel trial to assess the efficacy of brofaromine in the treatment of post traumatic stress disorder ( PTSD) failed to show a significant difference between the brofaromine and placebo treatment groups. The placebo response rate in this study was higher than that in previously published double-blind, placebo-controlled studies of PTSD.
|
Authors | D G Baker, B I Diamond, G Gillette, M Hamner, D Katzelnick, T Keller, T A Mellman, E Pontius, M Rosenthal, P Tucker |
Journal | Psychopharmacology
(Psychopharmacology (Berl))
Vol. 122
Issue 4
Pg. 386-9
(Dec 1995)
ISSN: 0033-3158 [Print] Germany |
PMID | 8657838
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
- Monoamine Oxidase Inhibitors
- Piperidines
- brofaromine
|
Topics |
- Adult
- Aged
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Monoamine Oxidase Inhibitors
(adverse effects, therapeutic use)
- Piperidines
(adverse effects, therapeutic use)
- Stress Disorders, Post-Traumatic
(drug therapy)
|